Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Psychosis and Schizophrenia Among Patients With Epilepsy: A Systematic Review and Meta-Analysis Publisher Pubmed



Thapa S1 ; Panah MY2, 3 ; Vaheb S3 ; Dahal K4 ; Maharjan PM5 ; Shah S5 ; Mirmosayyeb O3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Westchester Medical Center, New York Medical College, Valhalla, NY, United States
  2. 2. Student Research Committee, Shahrekord University of Medical Sciences, Shahrekord, Iran
  3. 3. Isfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  4. 4. Tribhuvan University, Institute of Medicine, Maharajgunj, 44600, Nepal
  5. 5. Central Department of Public Health, Maharajgunj, 44600, Nepal

Source: Epilepsy Research Published:2024


Abstract

Background: Prior research has indicated an association between epilepsy and psychosis. This review aimed to estimate the global prevalence rate of psychosis and schizophrenia in epilepsy and assess the odds of psychosis and schizophrenia among patients with epilepsy (PWE). Method: A comprehensive literature search was carried out utilizing relevant keywords in PubMed/MEDLINE and Scopus, covering from January 1, 1990, to November 18, 2023. The meta-analysis was performed using R software employing a random-effect model to establish the overall prevalence and odds ratio (OR), with 95 % confidence intervals (95 % CI), of psychosis and schizophrenia in epilepsy. Result: Eighty-one studies encompassing 970,497 PWE met the inclusion criteria. The meta-analysis revealed that the overall prevalence of psychosis and schizophrenia among PWE was 7.8 % (95 % CI: 6.3–9.2 %, I2 = 100 %) and 3 % (95 % CI: 1.7–4.3 %, I2 = 95 %), respectively. Moreover, epilepsy was associated with a threefold rise in the odds of psychosis (OR = 3.41, 95 % CI: 2.3–5.08, p-value < 0.01, I2 = 99 %, p-heterogeneity < 0.01). Furthermore, epilepsy was found to be significantly correlated with a fivefold increased odds of schizophrenia (OR = 5.22, 95 % CI: 2.99–9.11, p-value < 0.01, I2 = 94 %, p-heterogeneity < 0.01) Conclusion: Epilepsy can increase the risk of developing psychosis and schizophrenia. Additional longitudinal research is warranted to elucidate the influence of epilepsy and its treatments on the risk of psychosis and schizophrenia, and also a comprehensive suite of confounding adjustments will be requisite. © 2024 Elsevier B.V.
Related Docs
1. Valproate-Risperidone Valproate-Lithium Combination in Acute Mania, Journal of Research in Medical Sciences (2005)
2. Medication Adherence and Its Relationship With Self-Esteem Among Patients With Epilepsy in Isfahan, Iran, Epilepsy and Behavior (2024)
3. Brain-Derived Neurotrophic Factor Gene Val66met Polymorphism and Risk of Schizophrenia: A Meta-Analysis of Case–Control Studies, Cellular and Molecular Neurobiology (2016)
4. The Relation Between Body Mass Index and Demographic and Clinical Aspects Among Schizophrenia Patients, Journal of Isfahan Medical School (2010)
5. Sodium Valproate As an Adjunctive Drug in Treatment of Schizophrenia, Iranian Journal of Psychiatry and Behavioral Sciences (2007)
6. Coping Strategies and Their Relationship With Emotional Intelligence in Patients With Epilepsy Referred to Isfahan Epilepsy Society in 2017, Epilepsy and Behavior (2019)
7. Quality of Life in Epileptic Patients Compared With Healthy People, Medical Journal of the Islamic Republic of Iran (2016)
Experts (# of related papers)
View all Related Experts
Masoud Etemadifar (2)
Majid Barekatain (1)